Medically reviewed by Dr Sin Yong · Last reviewed · 10 min read · Jump to questions
Published 20 October 2026 · Reviewed by Dr Sin Yong

Body odour, called bromhidrosis when it is persistent and distressing, is produced when skin bacteria break down the secretions of apocrine sweat glands in the underarms and groin. Sweat itself is almost odourless. Treatment therefore works on the bacteria, the moisture that feeds them, or the glands. Dr Sin Yong assesses which is driving your odour, and checks for the medical causes that need a different doctor.
Part of Body →
The skin carries two kinds of sweat gland and they do different jobs. Eccrine glands, several million of them, are spread over the whole body and open directly onto the surface. They produce the watery sweat that cools you, and it is almost odourless: water, salt and traces of urea and lactate. Apocrine glands are far fewer, are confined to the underarms, groin, around the nipples and the ear canal, open into hair follicles rather than onto the skin, and only begin to work at puberty under the influence of sex hormones. Their secretion is thick, milky and rich in lipids, proteins and sulphur-containing precursors, and it is also odourless as it leaves the gland.

The smell is made on the skin. Bacteria that live in the moist, hairy underarm, chiefly corynebacteria and some staphylococci, metabolise apocrine precursors into short volatile fatty acids with a rancid, cheese-like note and into thioalcohols with the sharp, sulphurous quality people describe as onion. Eccrine sweat does not supply the precursors, but it supplies the wet environment and dilutes the acidity of the skin, which lets the bacteria thrive, and underarm hair gives them more surface and holds the volatile products close. So apocrine bromhidrosis, the common form, needs three ingredients at once: apocrine secretion, bacteria and moisture. Take away any one and the odour falls.
Eccrine bromhidrosis is different and less common. It arises where eccrine sweat macerates the outer skin layer, usually on the feet or in skin folds, and bacteria then digest the softened keratin; the smell is more sour and the sites are different. It responds to keeping the area dry rather than to anything aimed at apocrine glands, which is one reason the site of the odour is the first thing asked about.

Apocrine activity varies enormously between people, and part of the variation is written in a single gene. A common variant of ABCC11 reduces the secretion of odour precursors by apocrine glands, and the same variant produces dry, flaky earwax instead of wet. It is carried by most people of East Asian ancestry and by a minority of Europeans and Africans, which is why axillary odour is reported far less often in Chinese, Japanese and Korean populations and why dry earwax and low odour so often go together. In Singapore's mixed population this matters clinically: in someone with dry earwax, a new complaint of strong underarm odour prompts a closer look at bacteria, skin folds, products and medical causes rather than at the glands.
Other things that raise odour are more ordinary. Dense underarm hair, synthetic fabrics that trap moisture, humidity, infrequent changes of clothing, diets heavy in garlic, onion, cruciferous vegetables or spices whose sulphur compounds are excreted in sweat, alcohol, stress and anxiety which drive apocrine as well as eccrine output, hormonal shifts at puberty, around periods, in pregnancy and at the menopause, and some medicines. Excessive eccrine sweating on its own, hyperhidrosis, does not smell, but it makes an odour that is already there worse by keeping the skin wet, and the two are often treated together.
“Sweat does not smell. Bacteria eating sweat smell. So before I inject anything I want to know you have starved them of hair and moisture for a month, and if your earwax is dry I want to know why you smell at all.”
Dr Sin YongOn body odour
Because odour needs bacteria and moisture, the baseline removes both, and for many people it is the whole answer. It is listed before the clinical options because Dr Sin Yong will not inject or treat an underarm that has not first been managed this way.

If the odour persists after a genuine month of this, the problem is apocrine output or sweat volume, and the clinical options below are considered.

The clinical options act at different points in the chain, and it helps to know which before comparing them.
Botulinum toxin injected into the skin of the underarm blocks the nerve signal that tells sweat glands to secrete. Its main and well-established use is for excessive eccrine sweating, and by drying the underarm it removes the moisture that bacteria need, which is why odour falls with it. There is also direct evidence for bromhidrosis: a 2019 randomised, double-blind, side-by-side trial found reduced odour scores on the treated side with histological changes in the sweat glands, and a 2024 review in Dermatologic Surgery covers its use for apocrine as well as eccrine gland disorders. The effect wears off and is repeated; the molecule is a prescription medicine placed by a doctor. This is the injectable rung Dr Sin Yong uses for sweat-driven odour, after the baseline has been tried, and the areas and technique are described on the botulinum toxin page.
A microwave device delivers energy to the junction of the dermis and fat where both eccrine and apocrine glands sit, and destroys them by heat with surface cooling. It was developed for axillary hyperhidrosis and has been studied for bromhidrosis, with 2025 histological work in Dermatologic Surgery showing apocrine gland changes. Because destroyed glands are not replaced, it is described as lasting, with swelling, numbness and tenderness afterwards that settle gradually. It is not used at this practice; the comparison with toxin is on miraDry vs botulinum toxin.
Subdermal laser, using a fibre passed under the skin of the underarm to heat the gland layer, and suction-curettage or open excision of the apocrine tissue are described in the surgical literature, mostly from East Asia where apocrine bromhidrosis in a person without the protective gene variant can be severe. They carry the risks of any procedure under the skin, including seroma, scarring, skin necrosis and recurrence, and they are plastic surgery or dermatological surgery procedures, not offered here. A 2023 literature review in the Journal of the American Academy of Dermatology sets out all these modalities side by side.
| Option | Acts on | Lasts | Here |
|---|---|---|---|
| Antibacterial wash, antiperspirant, hair removal | Bacteria and moisture | While continued | Baseline for everyone |
| Topical antibiotic | Bacteria | Short course only | Prescribed after examination |
| Botulinum toxin injection | Sweat signal to the glands; moisture and apocrine output | Wears off; repeated | Used, for sweat-driven odour |
| Microwave gland reduction | Eccrine and apocrine glands by heat | Described as lasting | Not used here |
| Subdermal laser, curettage, excision | Apocrine tissue removed or destroyed | Described as lasting; recurrence reported | Not offered; referred |
Most bromhidrosis is local and harmless. A minority of odour complaints are the first sign of something else, and these are referred rather than treated.
For odour that is genuinely apocrine and local, what decides the plan is the site, the contribution of eccrine sweating, hair density, skin phototype where laser hair removal is part of it, the response to a proper baseline, and your tolerance for a treatment that is repeated. After botulinum toxin injection, expect small bumps and occasional bruises that settle, no pressure on the area that day, and a review before any repeat; after laser hair removal, the usual sun avoidance and bland care described in the aftercare hub. The fee follows what is chosen and is set out in writing after the consultation.
Every treatment is performed by Dr Sin Yong personally. Singapore Medical Council registered · invited to share his clinical expertise internationally for CLASSYS, DEKA, Fotona, Hironic and Ilooda.
Try the hygiene baseline for a month first, and bring a note of what you used and when. How consultations work.
WhatsApp Dr Sin Yong →or use the enquiry formShowering removes sweat but leaves most of the resident bacteria that make the smell, and ordinary deodorant masks rather than reduces it. An antibacterial wash, an aluminium antiperspirant applied to dry skin at night, hair removal and a fresh shirt daily remove the bacteria and the moisture they need. If a month of that does not help, apocrine output or sweat volume is the driver and clinical options are considered.
It reduces it in many people by blocking the signal to the sweat glands, so the underarm is drier and bacteria have less to work on; a randomised trial has also shown reduced odour scores and changes in the sweat glands themselves. The effect wears off and is repeated. Dr Sin Yong uses it for sweat-driven odour after the hygiene baseline has been tried, and only after assessment.
Microwave gland reduction and surgical or laser removal of apocrine tissue are described as lasting because destroyed glands are not replaced, with recurrence reported for the surgical methods. They carry procedure risks, and none is offered at this practice; the comparison with botulinum toxin is on a separate page, and a referral is written if that route is appropriate.
A common variant of the ABCC11 gene reduces the apocrine secretion of odour precursors and also produces dry earwax; most people of Chinese, Japanese and Korean ancestry carry it. If you have dry earwax and a new, strong odour, the cause is more likely bacteria in a fold, hair, products or a medical change than apocrine glands, which changes what is examined and treated.
When it is new, affects the whole body or breath, smells sweet, fishy or of ammonia, or comes with thirst, weight loss, fever or fatigue; these point to diabetes, liver, kidney, thyroid or metabolic causes and need a GP and blood tests. Odour from a rash, fold, wound or discharge is infection. Odour that others cannot detect is also a reason to talk to a GP rather than to treat the underarm.
Bromhidrosis treatment modalities: A literature review. Journal of the American Academy of Dermatology, 2023. source
Efficacy and safety of botulinum toxin A in axillary bromhidrosis and associated histological changes in sweat glands: a prospective randomized double-blind side-by-side comparison clinical study. Dermatologic Surgery, 2019. source
Using neuromodulators for salivary, eccrine, and apocrine gland disorders. Dermatologic Surgery, 2024. source
Clinical and histologic correlation of dermal microwave energy for axillary bromhidrosis. Dermatologic Surgery, 2025. source
About this page: written and medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last reviewed 20 October 2026 · Illustrative images only, not patients · Editorial policy
Consultations by appointment at Orchard Road, Singapore.
Replies within clinic hours: Mon–Fri 10am–8pm, Sat 11am–3pm · How consultations work · Prefer not to use WhatsApp? · Treatment finder
WhatsApp +65 8023 7170 →